Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Biogen Idec
(NQ:
BIIB
)
187.21
+0.15 (+0.08%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 4, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biogen Idec
< Previous
1
2
...
19
20
21
22
23
24
25
26
27
...
59
60
Next >
Biogen Completes Acquisition of Reata Pharmaceuticals
September 26, 2023
From
Biogen Inc.
Via
GlobeNewswire
Amazon Invests $4B In ChatGPT Competitor, Hollywood Writers Accept Tentative Deal, ChatGPT Challenges Siri And Alexa With Introduction Of Verbal Responses: Today's Top Stories
↗
September 25, 2023
Benzinga
Via
Benzinga
Japan's Regulatory Authority Approves Biogen/Eisai's Alzheimer Treatment Leqembi
↗
September 25, 2023
Eisai Co Ltd (OTC: ESALY) (OTC: ESALF) and Biogen Inc (NASDAQ: BIIB) announced that humanized anti-soluble aggregated amyloid-beta (A&be
Via
Benzinga
(BIIB) - Analyzing Biogen's Short Interest
↗
September 20, 2023
Via
Benzinga
$100 Invested In Biogen 15 Years Ago Would Be Worth This Much Today
↗
September 15, 2023
Via
Benzinga
$1000 Invested In Biogen 15 Years Ago Would Be Worth This Much Today
↗
September 04, 2023
Via
Benzinga
Are Gene Therapy Stocks The Market's Next Big Winners?
September 25, 2023
Biotechs Sarepta and BioMarin are among companies advancing cutting-edge gene therapies, although those treatments can come with a $2 million or more price.
Via
MarketBeat
Topics
Artificial Intelligence
LEQEMBI® Intravenous Infusion (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Japan
September 25, 2023
From
Biogen Inc.
Via
GlobeNewswire
California Attorney General Cracks Down On Deceptive Abortion Pill Reversal Claims
↗
September 22, 2023
California Attorney General Rob Bonta has taken legal action against two anti-abortion organizations, Heartbeat International (HBI) and RealOptions Obria, for making unsupported claims about reversing...
Via
Benzinga
Does Biogen's Latest $1.5 Billion-Dollar Move Make It a Buy?
↗
September 09, 2023
Buying a biotech is a good move, but it might not be enough to entice investors.
Via
The Motley Fool
(BIIB) - Analyzing Biogen's Short Interest
↗
September 01, 2023
Via
Benzinga
Analyst Ratings for Biogen
↗
August 29, 2023
Via
Benzinga
Better Buy: Biogen vs. Eli Lilly
↗
August 29, 2023
This battle of biotech giants has a clear winner.
Via
The Motley Fool
7 Pharma Stocks to Buy for Groundbreaking Treatments and Robust Revenue Growth
↗
September 07, 2023
Finding the best pharma stocks to buy takes a little effort, but it will pay of with these seven long-term winners.
Via
InvestorPlace
Denali Therapeutics Breakthrough Blood-Brain Barrier Platform A Game-Changer in Neurodegenerative Diseases: Analyst
↗
September 06, 2023
B Riley Securities initiated coverage on Denali Therapeutics Inc (NASDAQ: DNLI) with a Buy rating and a
Via
Benzinga
3 Healthcare Stocks to Sell in September Before They Crash & Burn
↗
September 06, 2023
The prognosis for these healthcare stocks isn't optimistic so plan to sell them this month before they get worse.
Via
InvestorPlace
Upcoming Phase 2 Data Expected For Longeveron's (NASDAQ: LGVN) Drug For the $4+ Billion Alzheimer's Sector – What To Look For
↗
September 06, 2023
Longeveron (NASDAQ: LGVN), a clinical-stage biopharma developing potential treatments for age-related and life-threatening diseases, is expecting data from its phase 2a trial for its Lomecel-B™...
Via
Benzinga
Biogen Appoints Jane Grogan as Head of Research
September 06, 2023
From
Biogen Inc.
Via
GlobeNewswire
If You Invested $100 In This Stock 15 Years Ago, You Would Have $500 Today
↗
August 14, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023
↗
September 06, 2023
Via
Benzinga
The 3 Best Biotech Stocks to Buy Now: September 2023
↗
September 04, 2023
With the biotech sector looking poised to continue its rally further, investors would do well to buy these stocks to capitalize.
Via
InvestorPlace
Sage Therapeutics Cuts Workforce By 40% Following Rejection In Depression Treatment
↗
August 31, 2023
The company is now focusing on its launch in postpartum depression.
Via
Investor's Business Daily
The 7 Most Promising Momentum Stocks to Own Now
↗
August 31, 2023
These momentum stock picks are on a run, but it isn't too late to ride the rollercoaster amid broad market volatility.
Via
InvestorPlace
The 3 Most Promising Pharma Stocks to Own Now
↗
August 30, 2023
A pillar to economic growth in a defensive area, these promising pharma stocks are set to rise and give investors one bullish ride.
Via
InvestorPlace
Wall Street Thinks This Tiny Biotech Company Could Soar Soon
↗
August 28, 2023
An upcoming regulatory decision could prove to be an inflection point in the biotech's life cycle.
Via
The Motley Fool
Insider Richard Barry Just Doubled Down on Cassava (SAVA) Stock
↗
August 24, 2023
Cassava had $168.4 million of cash at the end of June after losing $28.7 million during the second quarter of 2023. SAVA stock is up 5%
Via
InvestorPlace
Is Sage Therapeutics Stock in Trouble After Dropping 50% in a Month?
↗
August 24, 2023
The pharmaceutical company's growth prospects have taken a big hit.
Via
The Motley Fool
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Fiesta Restaurant Group, Inc. (Nasdaq - FRGI), Veritiv Corporation (NYSE - VRTV), New Relic, Inc. (NYSE - NEWR), Reata Pharmaceuticals, Inc. (Nasdaq - RETA)
August 17, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
Why Shares of Sage Therapeutics Slumped This Week
↗
August 11, 2023
The company got bad news from the FDA and saw increased losses.
Via
The Motley Fool
Could This $6.5 Billion Acquisition Help Turn Biogen's Business Around?
↗
August 10, 2023
The company's rare disease portfolio may soon get an upgrade.
Via
The Motley Fool
< Previous
1
2
...
19
20
21
22
23
24
25
26
27
...
59
60
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
